UBS Group’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.8K | Sell |
1,524
-383
| -20% | -$11.3K | ﹤0.01% | 6569 |
|
|
2025
Q1 | $69.6K | Buy |
1,907
+1,643
| +622% | +$60K | ﹤0.01% | 6054 |
|
|
2024
Q4 | $22.4K | Buy |
264
+259
| +5,180% | +$22K | ﹤0.01% | 6569 |
|
|
2024
Q3 | $985 | Buy |
+5
| New | +$985 | ﹤0.01% | 7541 |
|
|
2024
Q1 | – | Hold |
0
| – | -$88 | – | 8111 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7724 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | -$1.26K | – | 7817 |
|
|
2023
Q1 | $1.26K | Buy |
+1
| New | +$1.26K | ﹤0.01% | 7674 |
|
|
2022
Q3 | – | Sell |
-11
| Closed | -$10K | – | 9202 |
|
|
2022
Q2 | $10K | Buy |
11
+9
| +450% | +$8.18K | ﹤0.01% | 6905 |
|
|
2022
Q1 | $3K | Sell |
2
-7
| -78% | -$10.5K | ﹤0.01% | 8364 |
|
|
2021
Q4 | $12K | Sell |
9
-12
| -57% | -$16K | ﹤0.01% | 7421 |
|
|
2021
Q3 | $25K | Sell |
21
-68
| -76% | -$81K | ﹤0.01% | 5778 |
|
|
2021
Q2 | $71K | Buy |
89
+85
| +2,125% | +$67.8K | ﹤0.01% | 5076 |
|
|
2021
Q1 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 7553 |
|